Artwork runs in Per-country
Label artwork, on-pack copy and retail packaging for Asia-Pacific are written in Per-country. Plan translation and claims review alongside sampling so production is not waiting on artwork.
General private-label supplement manufacturing across the full multi-format catalogue. Formula, specification, samples and documentation move through one structured order workflow, reviewed for APAC brands. The brand owner remains the responsible party on pack.
How to choose a manufacturing partner for APAC brands — a reviewed catalogue, documentation by stage, and one structured order workflow.
DAT Supply manufactures private-label dietary supplements for APAC brands across a multi-format platform.
Three things matter most: a reviewed formula base, a documented specification process, and a clear target-market claims review — before a sample is ever produced.
A private-label catalogue option that has already been through formulation review, rather than a formula built from zero for every enquiry.
Specification, label and batch documents released at defined project stages — not bundled into a single opaque handoff at the end.
On-pack copy and claim wording reviewed against the framework that applies for APAC brands, before artwork is locked.
Brands for APAC brands typically weigh a local co-packer against an EU-wide or international manufacturing platform. Neither is right by default — it depends on volume, format range and how many markets the brand plans to enter.
Can suit a single-market launch with a narrow format range and simple logistics — but often means re-briefing from scratch when the brand adds a second market or a second format.
One structured order workflow across formats and markets, with documentation reviewed per project against each target-market framework — useful once a brand plans to sell beyond a single market.
A single contracting party for the full private-label build: formula, specification, samples, documentation and production, managed through one client workspace.
Gummies, sachets, functional jellies, oral strips and pet soft chews run through the same order workflow, so a concept can move between formats without re-briefing.
Each project moves through defined review steps — brief, spec, artwork, release — inside one client workspace, not a vendor inbox.
Format is chosen against the brief. The same concept can move between packaging types without re-briefing.
Pectin-based supplement gummies — the mature DAT Supply format. Used across daily wellness, beauty, sleep and kids ranges.
Single-serving powder sachet / stick format for powders, granulates and mix-in daily-routine concepts. Configuration confirmed per project.
Pouchable functional jelly format for daily-routine and on-the-go supplement concepts.
Fast-dissolving oral strip format. Reviewed per project; payload range confirmed during the brief.
Dropper-bottle supplement format for oil-soluble or precise-dose actives.
Soft, paste-based chew format for cats and dogs. Format and palatability confirmed per project — no pet therapeutic claims.
Private-label catalogue
Your brand on a reviewed catalogue option. Project-specific personalisation is reviewed after order start.
Qualified custom development
A formula developed against your brief for qualified 5,000+ unit projects, after a paid feasibility/R&D review.
Final option, packaging configuration and minimum order quantity are confirmed against your brief inside the portal. Final timeline is confirmed during order setup.
Ready sample kits or development samples let you confirm texture, finish and packaging before committing to a full order.
Packaging options include PET bottle, doypack, blister and sachet, with pack configuration confirmed per project. Samples are ordered inside the DAT Supply portal, ahead of the full production run.
Each step is reviewed before the next review step opens.
Target format, quantity and claims direction, reviewed for APAC brands.
Private-label catalogue or qualified custom development — confirmed against the brief.
Per-SKU specification + allergen statement drafted, then locked.
Confirm format, finish and packaging with a sample before the full run.
Dieline + on-pack copy reviewed against the target-market framework.
Production runs through the controlled workflow; batch-release documents issued after QC release.
Each document is released to the brand owner at its project stage. The Certificate of Analysis is batch-specific and issued after production — available on request, not as a standing public list.
DAT releases the standard documentation package by project stage. External testing, full COA, additional microbiological reports, heavy metals, pesticide residue reports or raw-material supplier documentation are reviewed and quoted separately unless included in the agreed project scope.
Production is reviewed against the US market: structure/function claim wording, the Supplement Facts panel and % Daily Value formatting are checked per project before artwork is locked. The brand owner remains the responsible party and importer of record on pack. Claim wording reviewed per project against the target market; final responsibility remains with the brand owner.
Asia-Pacific is an umbrella market covering 13 Asia-Pacific markets (Singapore, Japan, Korea, Australia, India and others). The combined consumer population is approximately 4.3 billion people, with Singapore as the largest single commercial city. Key commercial cities across the umbrella include Singapore, Tokyo, Seoul, Sydney, Hong Kong, Kuala Lumpur. On the supplement industry signal: Fragmented across 13 markets; Singapore + Hong Kong serve as regional supplement-import hubs; Korea + Japan have the most demanding label-review regimes. APAC operates per-country: HSA in Singapore, MFDS in Korea, MHLW in Japan, TGA in Australia, MoHFW in India. There is no shared notification path; each market has its own ingredient lists, claim frameworks and label-language rules. For brand owners briefing DAT Supply at the umbrella level, the working assumption is that artwork is produced once with country-specific variants, regulatory notification is filed per-market by the brand owner as food business operator, and the manufacturing project is coordinated centrally to consolidate ingredient sourcing, packaging and documentation. Country-level guides for each market in the umbrella are linked under the internal links section.
Supplement regulation across Asia-Pacific operates strictly per-country with no shared acquis. The competent authorities by major market: HSA (Health Sciences Authority) in Singapore; MFDS (Ministry of Food and Drug Safety) in Korea; MHLW (Ministry of Health, Labour and Welfare) in Japan with the Foods with Function Claims (FFC) and Foods for Specified Health Uses (FOSHU) channels; TGA (Therapeutic Goods Administration) in Australia where supplements are regulated as listed or registered complementary medicines on the ARTG; MoHFW / FSSAI in India; MoH Vietnam, FDA Philippines, FDA Thailand and others. Notification routes vary from operator-led notification (Singapore, Vietnam) to mandatory pre-market authorisation (Korea, Japan FFC, China Blue Hat, Australia ARTG). Claim wording is country-specific: there is no shared authorised-claim register. Each market maintains its own ingredient lists, permitted claims and label-language rules. Common rejection patterns: (i) attempting to use applicable claims framework claim wording in markets that operate their own register, (ii) failing to translate into the country's official script (Korean Hangul, Japanese Kana/Kanji, Chinese Simplified, Vietnamese Latin with diacritics, Thai script), (iii) novel-ingredient submissions that lack the country-specific safety dossier. DAT's APAC working approach is to manufacture and document in the EU under the EU framework, then assemble the country-specific documentation overlay (artwork variant, claim wording, allergen declaration in local language, importer-of-record and notification number) for each target APAC market. The brand owner is the responsible party in every APAC market and either acts as its own importer-of-record or names a local agent; DAT supplies the technical documentation pack. Country-by-country notes that shape a brief: Singapore HSA operates a TCM-aware ingredient list and an operator-led notification with a defined responsible person; Korea's MFDS Health Functional Food list governs which actives can carry a functional claim and adopting the list shortcuts the authorisation step; Japan's FFC system requires a literature-based or trial-based scientific dossier filed with the Consumer Affairs Agency before market entry; Australia's TGA ARTG requires a sponsor with a complementary-medicine licence and aligns to the TGA permissible-ingredient list; China's Blue Hat is a multi-year State Administration registration; India's FSSAI operates a nutraceutical regulation with positive lists for vitamins, minerals and standardised botanicals; ASEAN markets (Vietnam, Philippines, Thailand, Malaysia, Indonesia) operate national notification schemes that increasingly reference ASEAN harmonised standards. Cross-border DTC: cross-border ecommerce (notably Tmall Global, JD Worldwide, iHerb cross-border) provides a route into China and other APAC markets without local notification; DAT's documentation pack is suitable for cross-border DTC where the product is shipped to a personal consumer rather than a domestic distributor.
Notification authority: Per-country (HSA Singapore, MFDS Korea, MHLW Japan, TGA Australia, MoHFW India)
Label artwork, on-pack copy and retail packaging for Asia-Pacific are written in Per-country. Plan translation and claims review alongside sampling so production is not waiting on artwork.
Food-supplement notification for Asia-Pacific is filed with Per-country (HSA Singapore, MFDS Korea, MHLW Japan, TGA Australia, MoHFW India). The notification and final on-pack claims remain the brand owner's responsibility; DAT supplies the supporting product documentation.
Fragmented across 13 markets; Singapore + Hong Kong serve as regional supplement-import hubs; Korea + Japan have the most demanding label-review regimes Reading the Asia-Pacific signal for a brand owner brief: APAC operates per-country: HSA in Singapore, MFDS in Korea, MHLW in Japan, TGA in Australia, MoHFW in India. There is no shared notification path; each market has its own ingredient lists, claim frameworks and label-language rules. The single artwork-base / per-country-variant approach is the standard working pattern across Asia-Pacific.
Private-label catalogue orders start from 1,000 units. Qualified custom development volumes are confirmed after the development scope. Final quantities are confirmed against your brief inside the portal.
Yes. Ready sample kits or development samples let you confirm format, finish and packaging before you start a full order.
Claim wording reviewed per project against the target market; final responsibility remains with the brand owner.
By project stage — specification and label first, then batch-release documents and a batch-specific Certificate of Analysis after production and QC release.
Create your account, complete your company profile and brief your order inside the DAT Supply portal. Format, route and minimum order quantity are confirmed once your brief has been reviewed.